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Gene expression of adenosine receptors along the nephron.
Background. In view of the multiple effects of adenosine on
kidney function, this study aimed to determine the expression
of adenosine receptors (AR) along the rat and mouse nephron.
Methods. For this purpose, we semiquantified mRNA abun-
dance for adenosine A1-, A2A-, A2B-, and A3 receptors by
RNAse protection and by reverse transcription-polymerase
chain reaction (RT-PCR) in the kidney zones and in the dif-
ferent nephron segments of mice and rats.
Results. We found very similar expression patterns for rat
and mice. For the kidney zones A1-AR mRNA and A2A-AR
mRNA abundance displayed a marked difference, with an in-
crease from cortex to the inner medulla. This was not seen for
A2B receptors, which showed in general a rather weak expres-
sion. Along the nephron, A1-AR was strongly expressed in the
thin limbs of Henle and in the collecting duct system and to
a lesser extent in the medullary thick ascending limb. A2A-
AR mRNA was clearly detected in glomeruli but not in other
nephron segments. A2B-AR mRNA was strongly expressed in
the cortical thick ascending limb of Henle and in the distal con-
voluted tubule. A3-AR mRNA was not found in any nephron
segment.
Conclusion. Our data demonstrate a distinct mutual expres-
sion of the AR subtypes along the nephron. A1 receptors are
expressed in medullary tubular structures, while A2B receptors
are predominant in cortical tubular structures. A2A receptor
expression in the kidney appears to be restricted to vascular
cells.
A board of evidence has accumulated that adenosine is
a relevant local regulator of kidney function. Thus, adeno-
sine modulates afferent and efferent arteriolar tone [1–3]
and affects glomerular filtration [4, 5]. Adenosine further-
more influences medullary vasa recta and consequently
medullary blood flow [6–10]. Adenosine affects renin se-
cretion from renal juxtaglomerular cells [11–14] and is
considered to be a signaling molecule for the tubular
glomerular feedback [3, 15]. Moreover, adenosine influ-
ences tubular transport [16–20] and A1-adenosine recep-
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tor (AR) antagonists may serve as potent, natriuretic,
and potassium-sparing diurectis [21, 22]. In the collect-
ing duct, adenosine antagonizes the effects of arginine
vasopressin [23]. Accumulating evidence, also, suggests
that adenosine may also antagonize detrimental inflam-
matory events in the course of ischemic renal failure [24,
25].
The effects of adenosine are mediated by specific re-
ceptors such as A1-AR, A2A-AR, A2B-AR, and A3-AR
[26]. Several studies have previously addressed partial as-
pects of the intrarenal localization of these adenosine re-
ceptors. These studies agree that A1-AR are expressed in
the preglomerular vessels, in the juxtaglomerular appa-
ratus, in the medullary collecting ducts [2, 27–29], and in
descending vasa recta of the outer medulla [30]. A2A-AR
appear to be mainly associated with renal blood vessels
[2, 30], A2B-AR was found in preglomerular vessels and
in descending vasa recta [29, 30], while A3-AR seem to be
barely detectable in the kidney [9, 29]. However, there is
still a substantial lack of knowledge about the precise in-
trarenal localization of adenosine receptors, particularly
with regard to A2A-AR, A2B-AR, and A3-AR. Thus,
functional data suggest that A1 receptor antagonist in-
hibit proximal tubular transport [21], while there exists
not yet a convincing demonstration of A1 receptor ex-
pression in the proximal tubule [27, 28]. Furthermore, it
has been reported that adenosine alters ion transport in
thick ascending limb of Henle’s loop [31]. For microdis-
sected medullary thick ascending loops of Henle a strong
A1-AR mRNA signal was reported [32], while in situ hy-
bridization and immunohistochemistry provided no ev-
idence for an expression of A1-AR mRNA there [27].
There is functional evidence for A2A receptors in pre-
glomerular vessels [2], while neither A2A-AR protein
nor mRNA are found in preglomerular vessels [27, 29].
On the other hand, in the whole kidney cortex, A2A re-
ceptor expression is well detectable [9, 29], raising the
question, where else in the cortex they might be ex-
pressed. Among the different kidney zones the highest
expression of A2A-AR mRNA has been reported for
the inner medulla [27], while A2A receptor protein was
previously demonstrated in the cortex and only a weak
protein abundance was found in the medulla [29].
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Table. 1. Sequence of primers used for reverse transcription-polymerase chain reaction (RT-PCR)
GenBank accession Size of PCR
number Upstream downstream primer product
b-actin NM07393 5′-CGGGATCCCCGCCCTAGGCACCAGGGT-3′ 286 bp
5′-GGAATTCGGCTGGGGTGTTGAAGGTCTCAAA-3′
A1 mouse GI:4884857 5′-CGGGATCCTACATCTCGGCCTTCCAGG-3′ 219 bp
5′-GGAATTCAGTAGGTCTGTGGCCCAATG-3′
A1 rat GI:2906014 5′-CGGGATCCTACATCTCGGCCTTCCAGG-3′ 219 bp
5′-GGAATTCAGTAGGTCTGTGGCCCAATG-3′
A2A mouse GI:2347037 5′-CGGGATCCGTCCCTGGCCATCATCGT-3′ 177 bp
5′-GGAATTCGATCCTGTAGGCGTAGAT-3′
A2A rat GI:7407132 5′-CGGGATCCGTCCCTGGCCATCATCGT-3′ 293 bp
5′-GGAATTCCCCTCAGTGCTGTGAGC-3′
A2B mouse GI:6680655 5′-CGGGATCCTTTCACGGCTGCCTCTTC-3′ 256 bp
5′-GGAATTCCATCCCCCAGTTCTGTGC-3′
A2B rat GI:202587 5′-CGGGATCCAGCAGGACGCGCTGTACG-3′ 406 bp
5′-GGAATTCGGAGTCAGTCCAATGCCAAAG-3′
A3 mouse GI:25020505 5′-CGGGATCCCGTTCCGTGGTCAGTTTG-3′ 348 bp
5′-GGAATTCGCAGGCGTAGACAATAGG-3′
A3 rat GI:6978452 5′-CGGGATCCGCTGTAGTGGGCAACATGC-3′ 563 bp
5′-GGAATTCGATGATGCACATGACAACCAG-3′
In view of the important renal effects of adenosine and
the existing uncertainties regarding the intrarenal local-
ization of adenosine receptor expression, our study aimed
to systematically semiquantitate adenosine receptor gene
expression in the different nephron segments. To narrow
down species-specific expression, we performed our anal-
ysis in parallel in rat and mouse tissue.
METHODS
Animals
Animal experiments were conducted in accordance
with the National Institutes of Health (NIH) Guide for
the care and use of laboratory animals and the German
laws on the protection of animals. Male C57bl/6 mice (20
to 24 g) and male Sprague-Dawley rats (230 to 270 g),
which had free access to tap water and standard com-
mercial pellet chow (Altromin C-1000; Altromin, Lage,
Germany) were used.
Organ sampling and RNA extraction
Animals were killed by decapitation and kidneys were
immediately removed and cooled in 4◦C cold minimal
essential medium (MEM). The kidneys were carefully
separated in cortex and outer and inner medulla under
a stereomicroscope. The separated tissue was frozen in
liquid nitrogen. Total RNA was extracted from frozen
kidney zones stored at −80◦C according to the protocol
of Chomczynski and Sacchi [33]. After homogenization
in guanidine thiocyanate solution [4 mol/L, containing
0.5% N-lauryl-sarcosinate, 10 mmol/L ethylenedi-
aminetetraacetic acid (EDTA), 25 mmol/L sodium cit-
rate, and 700 mmol/L b-mercaptoethanol], 0.1 volume
2 mol/L sodium acetate (pH 4), 1 volume phenol (water
saturated), and 0.2 volume chloroform were added se-
quentially to the homogenate. After cooling on ice for
15 minutes, samples were centrifuged at 10,000g for
20 minutes at 4◦C. RNA in the supernatant was precipi-
tated with an equal volume of isopropanol at −20◦C for
at least 1 hour. The resulting RNA pellets were resus-
pended in guanidine thiocyanate solution, and again pre-
cipitated with an equal volume of isopropanol at −20◦C.
After washing the RNA pellets with 70% ethanol (EtOH)
the RNA was dissolved in diethylpyrocarbonate-treated
water, and stored at −80◦C until further processing. The
yield of RNA was measured at 260 nm.
RNase protection assay
The mRNA levels of the adenosine receptors A1-AR,
A2A-AR, and A2B-AR in different kidney zones were
measured by RNase protection assay. The A1-AR spe-
cific probe covers 219 bp, the A2A-AR probe 122 bp, and
the A2B-AR probe 406 bp plus a 60 bp polylinker se-
quence of the vector. In addition, b-actin was assayed by
RNase protection in all RNA samples as a housekeep-
ing gene product to obtain an internal control of RNA
quality.
For construction of the plasmid vectors, the frag-
ments of A1-AR, A2A-AR, and A2B-AR were amplified
(primers given in Table 1) with cDNA of rat kidney as
template in the polymerase chain reaction (PCR). The
amplified fragments were verified on a 2% agarose gel,
purified, and digested with BamH1 and EcoRI (Phar-
macia Biotech, Uppsala, Sweden). After separation on
a 2% agarose gel the DNA was extracted (QiaexII)
(Quiagen, Hilden, Germany) and ligated for 12 hours
at 14◦C into BamH1/EcoRI polylinker sites of vector
psp73 (Promega, Madison, WI, USA) for heat shock up-
take into Escherichia coli (JM109) (Promega). Due to
a BamH1 site in the 239 bp A2A-AR PCR fragment
the resulting DNA ligated into the psp73 vector covered
only 122 bp. Positive clones were grown and plasmids
were isolated (Maxi-Kit) (Quiagen). Accuracy of the
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constructed plasmids was conformed by a sequence anal-
ysis performed by Sequiserve (Vaterstetten, Germany).
Linearization of the plasmid vectors with HindIII was
followed by in vitro transcription with SP6 polymerase
(Promega) in the presence of a32P-guanosine triphos-
phate (GTP) (Amersham, Buckinghamshire, UK). The
radiolabeled antisense cRNA probes were hybridized
with total RNA in solution at 60◦C for 14 to 18 hours, then
digested with RNase A/T1 [reverse transcription (RT) for
30 minutes), and proteinase K added (37◦C for 30 min-
utes). After phenol/chloroform extraction and ethanol
precipitation, the protected probes were separated by
electrophoresis on 8% polyacrylamide gels. The amount
of radioactivity in the hybrids was assessed by a b-counter
and autoradiography was performed at −80◦C.
Real-time PCR analysis
Two micrograms of whole kidney, cortex, outer,
and inner medulla total RNA or resulting RNA pel-
lets of the microdissected tubules were reverse tran-
scribed into cDNA (20 lL) according to standard pro-
tocols. Real-time PCR was performed in a Light Cycler
(Roche, Mannheim, Germany). All experiments were
done using the Light Cycler DNA SYBR Green I Kit
(Roche). Each reaction contained 2 lL Master Mix
[including Taq polymerase, desoxynucleoside triphos-
phates (dTNPs), SYBR Green, buffer], 1 pmol of each
primer (Table 1), 3 mmol/L (b-actin, A1-AR, and A2A-
AR, and rat A3-AR) or 5 mmol/L MgCl2 (A2B-AR,
mouse A3-AR), and 2 lL cDNA. After 10 minutes
at 94◦C for activation of the Taq polymerase, the am-
plification program consisting of 15 seconds at 94◦C,
10 seconds at 60◦C, and 20 seconds at 72◦C was performed
for 50 cycles. The amplification was followed by a melting
curve analysis for control of the PCR products. As nega-
tive controls water and yeast tRNA instead of cDNA was
run with every PCR experiment. To verify the accuracy
of the amplification, PCR products were further analyzed
on ethidium bromide stained 2% agarose gels. Analysis
of the data was performed using Light Cycler software
3.5.3. Standard curves for adenosine receptor mRNAs
and b-actin mRNA were produced by using cDNA of
whole kidney or cortex, which was diluted 1:5, 1:10, 1:50,
1:100, and 1:1000. The ratio of the amount of adenosine
receptor mRNA and b-actin mRNA was calculated for
each sample.
Microdissection of nephron segments
and RT-PCR analysis
Nephron segments for RT-PCR and real-time PCR
were obtained by a modified collagenase digestion proto-
col developed by Schafer et al [34] and described by us in
detail elsewhere [35]. Collecting of the nephron segments
was carried out separately in cortex, outer, and inner
medulla over a time period of 3 to 4 hours after digesting.
For collecting thin limb (dTL/aTL) and inner medullary
collecting ducts (IMCD), the digested pieces of the in-
ner medulla were further separated with sharpened for-
ceps. The differentiated collected tubules were separately
transferred to a culture dish containing 0.25% bovine ser-
sum albumin (BSA) solution in MEM. The nephron seg-
ments were measured and at least 11 mm of each segment
[proximal convoluted tubule (PCT), proximal straight
tubule (PST), outer medullary descending thin limb of
Henle’s loop (dTL), inner medullary descending and
ascending thin limb (dTL/aTL), medullary and cortical
thick ascending limb of Henle’s loop (mTAL and cTAL,
respectively], distal convoluted tubule (DCT), connect-
ing tubule and cortical collecting duct (CT/CCD), outer
medullary and inner medullary collecting duct (OMCD
and IMCD, respectively) were pooled. In addition, at
least 22 glomeruli with and without arterioles attached
(Glom+ and Glom−, respectively) were collected. Col-
lected tubules were transferred to 400 lL GTC solution
(guanidine thiocyanate (4 mol/L) containing 0.5% N-
lauryl-sarcosinate, 10 mmol/L EDTA, 25 mmol/L sodium
citrate, 700 mmol/L b-mercaptoethanol) and stored at
−80◦C until RNA was extracted. Total RNA was ex-
tracted according to the protocol of Chomczynski and
Sacchi [33]. In brief, after defrosting the samples 12 lg
yeast tRNA, 0.1 volume 2 mol/L sodium acetate (pH 4), 1
volume phenol (water saturated), and 0.2 volume chloro-
form were added sequentially to the homogenate. After
cooling on ice for 15 minutes, samples were centrifuged
at 10,000g for 20 minutes at 4◦C. RNA in the supernatant
(360 lL) was precipitated with an equal volume of iso-
propanol at −20◦C for at least 1 hour. The resulting RNA
pellets were washed with 70% EtOH and finally dissolved
in 9 lL diethylpyrocarbonate-treated water and used for
RT using standard RT protocol. Resulting cDNA sam-
ples were diluted to a final concentration of 1 mm tubules/
2 lL and two glomeruli/2 lL. PCRs were performed in
a total volume of 20 lL in the presence of 2 lL cDNA
equivalent to 1 mm tubule or two glomeruli. Negative
controls included water instead of cDNA in the PCR,
and yeast tRNA (carrier used for RNA isolation) with
no further addition of RNA in the RT. As positive con-
trols for the PCR, cDNA of 0.2 lg whole kidney RNA
were amplified in all experiments. PCR was run with
30 seconds/94◦C denaturation, 30 seconds/60◦C anneal-
ing, and 1 minute/72◦C extension using standard PCR
protocols. PCR amplification was done with primers
given in Table 1. Analysis of PCR products was performed
after size separation by ethidium bromide-stained 2%
agarose gel electrophoresis. For control of RNA isolation
and RT, PCR with b-actin primers (30 cycles) were per-
formed. In all samples, b-actin was equally amplified with
cDNA equivalent to 1 mm tubule length or two glomeruli.
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PCR of all adenosine receptors were performed on
the cDNA derived from at least three different sets of
nephron segments from different rats and mice. Each set
always included Glom, PCT, PST, dTL, dTL/aTL, mTAL,
cTAL, DCT, CT/CCD, OMCD, and IMCD. In rat tis-
sue, vasa recta of the outer medulla (VROM) were also
collected.
RESULTS
Zonal distribution of A1-AR, A2A-AR,
and A2B-AR mRNA
Expression of A1-AR, A2A-AR, and A2B-AR mRNA
was analyzed by RNase protection assay in total RNA
of kidneys of six rats (Fig. 1). All three receptor mRNAs
were detected in cortex and outer and inner medulla. The
A2A-AR showed the highest overall mRNA expression
level in the whole kidney, followed by A1-AR mRNA
and A2B-AR mRNA abundance. The ratio of the overall
abundance of A1-AR, A2A-AR, and A2B-AR mRNA
in the whole rat kidney was 1:2.6:0.6. The expression of
the A3-AR mRNA could be detected only by RT-PCR
with a cycle number higher than 32.
The intrarenal distribution of the A1-AR, A2A-AR,
and A2B-AR gene expression was determined by RNase
protection assay in the different kidney zones, namely,
cortex and outer and inner medulla, in six rats. The ex-
pression of the A1-AR was highest in the inner medulla
and lowest in the cortex (Fig. 1). The relative expres-
sion level (normalized to cortex) for the A1-AR mRNA
abundance was 1:6:29 for cortex, outer medulla, and in-
ner medulla, respectively. The expression of the A2A-AR
gene was also the highest in the inner medulla and lowest
in the cortex yielding a ratio of 1:4:10 for cortex, outer
medulla, and inner medulla, respectively. The expression
of the A2B-AR gene was rather weak in all kidney zones.
The interzonal ratio of A2B-AR mRNA was 1:1.7:2.0, for
cortex, outer medulla, and inner medulla, respectively.
We also determined the interzonal expression of the
adenosine receptor mRNAs by real-time PCR for fur-
ther validation of the method (Fig. 2). Using total RNA
of four out of the six animals analyzed in Figure 1, we
found for A1-AR mRNA a ratio of 1:4:27, for A2A-
AR mRNA a ratio of 1:3:11, and for A2B-AR mRNA
a ratio of 1:1.2:1.2 for cortex, outer medulla, and inner
medulla, respectively. As these data were very similar to
that obtained by RNAse protection, we considered real-
time PCR as a robust method to semiquantitate mRNA
in smaller samples of total RNA.
Distribution of the adenosine receptor
mRNAs in nephron segments
The localization of the A1-AR mRNA, A2A-AR
mRNA, A2B-AR mRNA, and A3-AR mRNA along the
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Fig. 1. Abundance of A1-AR mRNA, A2A-AR mRNA, and A2B-AR
mRNA in the rat kidney zones cortex, outer medulla (OM) and inner
medulla (IM) relative to b-actin mRNA levels. The expression level of
A1-AR mRNA (A) and A2A-AR mRNA (B) was highest in the inner
medulla, whereas A2B-AR (C) was distributed equally in the three
zones (mean ± SEM; N = 6 each). Inset shows autoradiographs of a
representative RNAse protection assay with P32-labeled A2B receptor
(A2B), A1 receptor (A1), and A2A receptor (A2A) probes.
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Fig. 2. Expression profile of the A1-AR mRNA, A2A-AR, and A2B-
AR mRNA in rat kidney cortex, outer and inner medulla relative to b-
actin mRNA determined by real-time reverse transcription-polymerase
chain reaction (RT-PCR) (mean ± SEM; N = 4 each).
rat and mouse nephron was investigated by RT-PCR.
Each receptor mRNA was tested at least on three dif-
ferent pools of nephron segments, including glomeruli
(Glom), PCT and PST, dTL and dTL/aTL, mTAL and
cTAL, DCT, CT/CCD, and OMCD and IMCD. Each pool
contained material from three to five animals.
A1-AR mRNA localization
In microdissected segments A1-AR mRNA (Fig. 3A)
was strongly expressed in dTL and dTL/aTL and OMCD
and IMCD both in rats and mice. A weaker A1-AR
mRNA abundance was found in CT/CCD, mTAL, cTAL,
and DCT and in glomeruli with and without arterioles
(Glom+ and Glom−, respectively). Only a very faint sig-
nal was obtained for PCT and PST. The localization of
A1-AR mRNA was confirmed in four and three differ-
ent pools, respectively, of collected nephron segments of
rats and mice.
Since the juxtaglomerular portion of afferent arteri-
oles is considered as a main target of A1-AR action,
the moderate expression of A1-AR mRNA in glomeruli
was somewhat unexpected. We therefore semiquanti-
tated A1-AR mRNA by real-time PCR in three different
pools of microdissected glomeruli either with (Glom+) or
without (Glom−) visible attached afferent arterioles, each
pool comprising 80 glomeruli. For comparison, the A1-
AR mRNA abundance (A1-AR mRNA/b-actin mRNA)
in the glomeruli pools was set into proportion with the
A1-AR mRNA abundance in the whole kidney (i.e.,
100%).
In rats, the pools of Glom+ and Glom− contained on
average an A1-AR mRNA abundance of 56% and 21% of
the whole kidney, respectively. The respective values for
mouse kidneys were 23% for Glom+ and 10% for Glom−
(Fig. 3B). These data suggest that the afferent arteriole
rather than the glomerulus expresses A1-AR mRNA and
that the expression level there is below the average of the
whole kidney.
A2A-AR mRNA localization
RT-PCR for A2A-AR mRNA was performed with four
rat and three mouse pools of microdissected nephron seg-
ments. The PCR product was always found in the whole
kidney and in the glomeruli, while all other nephron
segments produced only faint bands (Fig. 4A). Even in
glomeruli, the A2A-AR mRNA level appeared relatively
low when compared with the expression in the whole
kidney. The relative abundance of glomerular A2A-AR
mRNA related to mouse cortex as measured by real-
time PCR in three different pools of microdissected
glomeruli either with (Glom+) or without (Glom−) vis-
ible attached afferent arterioles revealed a 3.5-fold en-
richment of A2A-AR mRNA in glomeruli relative to the
cortex (Fig. 4B). There was no difference in the expres-
sion level of A2A-AR mRNA between glomeruli with or
without attached afferent arteriole (Fig. 4).
A2B-AR mRNA localization
RT-PCR for A2B-AR mRNA was performed with four
rat and three mouse pools of microdissected nephron seg-
ments. In both species the A2B-AR transcript was de-
tected in the distal tubules (Fig. 5). In rats, the expression
in the distal tubules was restricted to the cTAL and DCT.
A weak expression was furthermore found in CT/CCD.
In mice RT-PCR of the A2B-AR mRNA revealed the
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Fig. 3. (A) Nephron distribution of adeno-
sine receptor A1-AR mRNA in microdis-
sected nephron segments of the rat (r-A1-
AR) and mouse (m-A1-AR) kidney. Repre-
sentative ethidium bromide-stained agarose
gel displaying the distribution of the A1-AR
receptor mRNA after reverse transcription-
polymerase chain reaction (RT-PCR) (rat 34
cycles; mouse 36 cycles). (B) Expression level
of the A1-AR mRNA relative to b-actin
mRNA in microdissected glomeruli of rat
and mouse kidney assayed by real time PCR
(N = 3 each). The A1-AR mRNA/b-actin
mRNA level in the glomeruli was compared
mRNA level of the whole kidney (100%)
of the rat and mouse, respectively. Abbre-
viations are: Glom+, glomeruli with arte-
rioles; Glom−, glomeruli without arterioles
attached; PCT, proximal convoluted tubule;
PST, proximal straight tubule; dTL, outer
medullary descending thin limb of Henle’s
loop; dTL/aTL, inner medullary descending
and ascending thin limb of Henle’s loop;
mTAL, medullary thick ascending limb of
Henle’s loop; cTALH, cortical thick ascending
limb of Henle’s loop; DCT, distal convoluted
tubule; CT/CCD, connecting tubule and cor-
tical collecting duct; OMCD, outer medullary
collecting duct; IMCD, inner medullary col-
lecting duct; tRNA, negative control, kidney
0.2, 0.02, and 0.002 lg RNA from the whole
kidney as positive control for the PCR.
strongest expression in DCT and cTAL, and in addition
a weaker expression in mTAL and CT/CCD.
The expression of A2B-AR mRNA in glomeruli dif-
fered somewhat between rats and mice. In rats the expres-
sion of A2B-AR mRNA in glomeruli was always found
in microdissected glomeruli. In mice the A2B-AR tran-
script was only occasionally observed in glomeruli at trace
levels.
A3-AR mRNA localization
The overall abundance of A3-AR mRNA in the whole
kidney was rather low. Although A3-AR mRNA was de-
tected in the whole kidney with a high PCR cycle number,
was the A3-AR transcript not found in any nephron seg-
ment (Fig. 6). To rule out that faint signals obtained for
A3-AR mRNA in kidney was a primer related artifact, we
also assayed A3-AR mRNA in rat (Fig. 6, left panel) and
mouse (Fig. 6, right panel) brain, heart, and kidney. For all
experiments cDNA from 0.2 lg total RNA of each organ
was used. In contrast to the kidney produced brain and
heart strong bands for A3-AR mRNA in both animals
species, supporting the assumption that the abundance
of A3-AR mRNA in the kidney in fact is very low.
Distribution of the adenosine receptor mRNA in VROM
To determine the expression of adenosine receptors
in the medullary blood vessels we sampled VROM of
rats. cDNA derived from nine pools of bundles of vessels
(N = 9) was assayed for A1-AR, A2A-AR, A2B-AR,
and A3-AR mRNA. Representative results are shown in
Figure 7. All VROM of rat pools were clearly positive
for A1-AR mRNA and A2A-AR mRNA and to a lesser
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Fig. 4. (A) Nephron distribution of
adenosine receptor A2A mRNA in mi-
crodissected nephron segments of the rat
(r-A2A-AR) and mouse (m-A2A-AR)
kidney. The distribution of A2A-AR mRNA
after reverse transcription-polymerase
chain reaction (RT-PCR) with 32 cycles
(rat) and 36 cycles (mouse) is shown by
an ethidium bromide-stained agarose gel.
(B) Expression level of the A2A-AR
mRNA/b-actin mRNA in mouse glomeruli
compared to the expression level in the
rat cortex (100%). Abbreviations are:
Glom+, glomeruli with arterioles; Glom−,
glomeruli without arterioles attached; PCT,
proximal convoluted tubule; PST, proximal
straight tubule; dTL, outer medullary
descending thin limb of Henle’s loop;
dTL/aTL, inner medullary descending and
ascending thin limb of Henle’s loop; mTAL,
medullary thick ascending limb of Henle’s
loop; cTALH, cortical thick ascending limb of
Henle’s loop; DCT, distal convoluted tubule;
CT/CCD, connecting tubule and cortical
collecting duct; OMCD, outer medullary
collecting duct; IMCD, inner medullary
collecting duct; tRNA, negative control,
kidney 0.2, 0.02, and 0.002 lg RNA from the
whole kidney as positive control for the PCR.
extent also for A2B-AR mRNA. mRNA of the A3-AR
was not detected in any VROM in rat pool.
DISCUSSION
In our study on the gene expression of adenosine re-
ceptors in the rat and mouse kidney we found an overall
expression level of A2A-AR mRNA > A1-AR mRNA
>> A2B-AR mRNA >> A3-AR mRNA. This may not
necessarily reflect protein abundance but may be indica-
tive for the functional relevance of the respective recep-
tors in the kidney.
For the zonal A1-AR gene expression we found a
strong corticomedullary uphill gradient. This is in good
agreement with previous data obtained by in situ hy-
bridization [27]. The zonal distribution results from the
distinct expression pattern of the A1-AR gene along
the nephron, which showed marked corticomedullary
uphill gradients for the descending loop of Henle, for
the ascending loop of Henle and for the collecting duct
system. In the cortex, we also found a significant expres-
sion of the A1-AR gene in glomeruli in association with
afferent arterioles, while proximal tubules as the main
mass of the cortex were negative for A1-AR mRNA in
rats and mice. A rather similar expression pattern of the
A1-AR gene was previously reported by Weaver and
Reppert [27] and in part by Yamaguchi et al [32], except
the strong expression in the thin limbs of Henle, which is
for the time described in this study. In accordance with
the study by Weaver and Reppert [27] but in contrast to
the report by Yamaguchi et al [32], we found no strong
expression of A1-AR mRNA in the thick ascending limb
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Fig. 5. Nephron distribution of adenosine re-
ceptor A2B-AR mRNA in microdissected
nephron segments of the rat (r-A2B-AR) and
mouse (m-A2B-AR) kidney. Distribution of
A2B-AR mRNA after reverse transcription-
polymerase chain reaction (RT-PCR) with 36
cycles in rat (A) and mouse (B) shown by
an ethidium bromide-stained agarose gel. Ab-
breviations are: Glom+, glomeruli with arte-
rioles; Glom−, glomeruli without arterioles
attached; PCT, proximal convoluted tubule;
PST, proximal straight tubule; dTL, outer
medullary descending thin limb of Henle’s
loop; dTL/aTL, inner medullary descending
and ascending thin limb of Henle’s loop;
mTAL, medullary thick ascending limb of
Henle’s loop; cTALH, cortical thick ascending
limb of Henle’s loop; DCT, distal convoluted
tubule; CT/CCD, connecting tubule and cor-
tical collecting duct; OMCD, outer medullary
collecting duct; IMCD, inner medullary col-
lecting duct; tRNA, negative control, kidney
0.2, 0.02, and 0.002 lg RNA from the whole
kidney as positive control for the PCR.
of Henle. In addition, our data support previous reports
on the expression of A1-AR mRNA in medullary vasa
recta [30].
The expression of the A1-R in glomeruli and afferent
arterioles is in good agreement with a number of func-
tional studies indicating a vasoconstriction of afferent ar-
terioles by adenosine via A1-AR and inhibition of renin
secretion from the juxtaglomerular apparatus by adeno-
sine via A1-AR [36]. There is also evidence for a rele-
vant function of A1-AR to inhibit sodium transport [37]
and antagonize the action of antidiuretic hormone [38]
in the collecting duct system, in particular in the inner
medullary collecting duct. Rather contradictory are find-
ings about the existence of A1-AR in proximal tubules.
While functional studies suggest a strong natriuretic and
diuretic effect of A1-AR antagonists on proximal tubules
[21, 39, 40] we and others [27, 32] could not detect sig-
nificant A1-AR mRNA levels in this particular nephron
segment.
Our novel results showing the strong expression of the
A1-AR gene in the thin limbs of Henle await functional
explanation. If water resorption and sodium chloride re-
sorption are the main functions of the descending and as-
cending thin limbs, respectively, one may speculate that
adenosine via A1-AR affects these functions. Given that
A1-AR signals through inhibition of cyclic adenosine
monophosphate (cAMP) formation and through eleva-
tion of cytosolic calcium [41], it remains to be clarified
how these second messengers determine the function of
the thin loops of Henle.
As for A1-AR, we also found for the expression of the
A2A-AR gene a strong corticomedullary uphill gradient.
This is in accordance with a previous report [27]. Further-
more, the clear signals obtained for A2A-AR mRNA in
glomeruli with and without visible attached arterioles and
in microdissected vasa recta are in principle compatible
with previous conclusions and assumptions about the ex-
pression of the A2A-AR in afferent arterioles and in vasa
recta [2, 8, 27, 29, 30]. Considering the similar abundance
of A2A-AR mRNA in glomeruli with and without affer-
ent arteriole (Glom+ and Glom−), suggests that intra-
glomerular cells are a main site of A2A expression and
that A2A receptors are not enriched in afferent arterioles
relative to glomeruli. In analogy to our findings, the ex-
istence of A2A-AR in outer medullary descending vasa
recta (OMVR) in the rat was also previously shown [8,
30].
In contrast to the vascular structures, we obtained no
clear signal for A2A-AR mRNA in any tubule segment.
This was to our surprise since we found a similar signif-
icant expression as of A1-AR in the inner medulla for
A2A-AR mRNA. In contrast to A1-AR, neither thin
limbs nor collecting ducts contained significant amounts
of A2A-AR mRNA. Expression of A2A-AR in the inner
medulla in nontubular structures has previously already
been suggested by Weaver and Reppert [27]. By exclu-
sion, one can therefore infer that A2A-AR in the kidney
medulla is restricted to blood vessels and potentially to
interstitial cells. Such a restricted expression of A2A-AR
in medullary blood vessels would be in a good agreement
with the concept, that A2A-AR regulates the blood cir-
culation in the medulla [30, 42].
In contrast to A1-AR and A2A-AR we found an only
low abundance of A2B-AR mRNA in the whole kidney,
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Fig. 6. (A) Localization of the adenosine
receptor A3-AR mRNA in microdissected
nephron segments of the rat (r-A3-AR)
and mouse (m-A3-AR) kidney. Ethidium
bromide-stained agarose gel showing the
A3-AR mRNA after reverse transcription-
polymerase chain reaction (RT-PCR) with 39
cycles (rat) and 36 cycles (mouse) in the kid-
ney. (B) Abundance of A3-AR mRNA in the
rat (left panel, 34 cycles) and mouse (right
panel, 36 cycles) kidney, brain, and heart.
From each organ 0.2 lg RNA was used for
RT-PCR (except in mouse kidney 0.02 lg
and 0.002 lg were tested in addition). Ab-
breviations are: Glom+, glomeruli with arte-
rioles; Glom−, glomeruli without arterioles
attached; PCT, proximal convoluted tubule;
PST, proximal straight tubule; dTL, outer
medullary descending thin limb of Henle’s
loop; dTL/aTL, inner medullary descending
and ascending thin limb of Henle’s loop;
mTAL, medullary thick ascending limb of
Henle’s loop; cTALH, cortical thick ascending
limb of Henle’s loop; DCT, distal convoluted
tubule; CT/CCD, connecting tubule and cor-
tical collecting duct; OMCD, outer medullary
collecting duct; IMCD, inner medullary col-
lecting duct; tRNA, negative control, kidney
0.2, 0.02, and 0.002 lg RNA from the whole
kidney as positive control for the PCR.
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receptor mRNA after reverse transcription-
polymerase chain reaction (RT-PCR) (A1-
AR, 34 cycles; A2A-AR, 32 cycles; A2B-AR,
36 cycles; and A3-AR, 39 cycles). TRNA is
negative control, kidney: 0.2, 0.02, and 0.002
lg RNA from the whole kidney as positive
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the whole kidney as positive control for the PCR.
similar to a previous report [27]. In addition, our data in-
dicate that there is no clear intrarenal corticomedullary
expression gradient. The nephron analysis furthermore
indicates a species dependent expression of A2B-AR as-
sociated with glomeruli in rats but not in mice. In ac-
cordance with previous data we also found expression of
A2B-AR in vasa recta [30]. A novel finding of our study
is the significant expression of A2B-AR mRNA in the
cTAL and the DCT both in rats and mice.
While the expression of A2B-AR in renal arterioles
points toward a function of these receptors in the con-
trol of intrarenal blood flow [43], remains the function
of A2B-AR in the distal nephron more speculative and
must be determined therefore in future experiments.
The A3-AR gene was only very weakly expressed in the
whole kidney and we could not find gene transcripts in
tubules, glomeruli, or vasa recta. We therefore speculate
that the functional relevance of A3-AR in the kidney is
less than that for the other adenosine receptors. So far,
little is known about the potential effects mediated by
A3-AR in the kidney.
Altogether, our data show a distinct mutual expression
of the adenosine receptor subtypes along the nephron.
The A1 receptors are expressed in medullary tubu-
lar structures, while the A2B receptors predominate
in cortical tubular structures. A2A receptor expres-
sion in the kidney appears to be restricted to vascular
cells.
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